Bamosiran

DB12256InvestigationalProtein Based Therapies

Bamosiran has been used in trials studying the treatment of Glaucoma, Ocular Hypertension, and Open Angle Glaucoma.

Mechanism: Pharmacologically active on Beta-2 adrenergic receptor
Curator reviewed
Code names: SYL040012

Resolves to

Compound

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Bamosiran, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.